DiObex

DiObex, Inc., a clinical-stage company based in San Francisco, is developing unique, first-in-class therapies for the critically under-served metabolic disease market. Our pipeline products address the markets for the treatment of type 1 diabetes, type 2 diabetes and its co-morbidities such as hypertension, dyslipidemia and visceral adiposity (often referred to collectively as “metabolic syndrome”). Obesity is an additional therapeutic focus for the company

Contact Details: 600 Townsend Street, Suite 271 San Francisco California 94103 United States of America Tel: 415.551.0400 Fax: 15.551.4113 Email: info@diobex.com WWW: www.diobex.com/

Loading...

Press Releases on DiObex:
DiObex to Present at Canaccord Adams Diabetes and Obesity Conference	4th June, 2008	DiObex, Inc.	SAN FRANCISCO, June 4 /PRNewswire/ -- DiObex, Inc., a privately held biotechnology company focused on the development of therapeutics to treat metabolic disease, announced today that CEO David

DiObex Clinical Trials:
A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 290 times since April 2007, the link to the organisation's website has been followed 58 times

Recent Search Terms used to find this page: Diobex Careers | diobex download | diobex download | diobex download | DIObex Inc. 2009 | diobex | .

Search for more companies in San Francisco

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for DiObex